Skip to content

A Study of the Effect of Suvarna Prashana in Children with Recurrent Respiratory Infection

Effect of Suvarna Prashana in Children with Recurrent Respiratory Infection: A Prospective Observational Case Control Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106773
Enrollment
120
Registered
2026-03-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

K G Mittal Ayurved College And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age group of 1yrto 12years of both the sexes were considered in the study. In cases group Children having history of recurrent respiratory infection episode of more than or equal to 3 episodes for last 6 months and receives the intervention will be selected from the balrog opd. For control group those children with similar condition who Will not opt for the intervention will be be considered in control group.

Exclusion criteria

Exclusion criteria: 1.Age less than 1years or more than 12 years 2.Chronic respiratory illness like pulmonary tuberculosis, lung disease, ashthma, chronic GI disorders.

Design outcomes

Primary

MeasureTime frame
Primary outcome is to study the reduction in the frequency and severity of recurrent respiratory infections assessed by symptom scores like soar throat, nasal congestion, nasal discharge, fever, sneezing and cough and epiosode countsTimepoint: Baseline is considered zero week at the time of enrollment, end of 8 week intervention after 2 month of weekly dosing and final follow up after 12 weeks captured by Case record form with telephonic checks to track RTI episodes, school absences and general health

Secondary

MeasureTime frame
Anthropometric study is considered for secondary outcomeTimepoint: Baseline is considered zero week at the time of enrollment, end of 8 week intervention after 2 month of weekly dosing and final follow up after 12 weeks captured by Case record form with telephonic checks to track RTI episodes, school absences and general health

Countries

India

Contacts

Public ContactDR RAKESH RAMRAJ TIWARI

K G Mittal Ayurved College And Hospital

drtiwarirakesh00@gmail.com9930108688

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026